Siltuximab: A Deep Dive into CNTO-328 and Its Clinical Applications Siltuximab represents a promising monoclonal agent targeting IL-6 receptor , offering a specific approach to addressing various neoplastic https://siltuximabreagent701794.wikiexpression.com/user